Prevalence of β-cell and thyroid autoantibody positivity in schoolchildren during three-year follow-up

Autoimmunity

Volumn 31, Issue 3, 1999, Pages 175-185

  Lindberg, Bengt ^a   Carlsson, Anneli ^d   Ericsson, Ulla Britt ^a   Kockum, Ingrid ^b   Lernmark, Åke ^c   Landin Olsson, Mona ^a   Sundkvist, Göran ^a   Ivarsson, Sten Anders ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF WASHINGTON   (United States)

^d University of Washington ^*

Author keywords

Autoantibodies; Autoimmunity; Thyroiditis; Type 1 diabetes mellitus

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; INSULIN ANTIBODY; PANCREAS ISLET CELL ANTIBODY; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; FOLLOW UP; HASHIMOTO DISEASE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; SCHOOL CHILD;

EID: 0033497464     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916939908994062     Document Type: Article

References (61)

1. Bachrach, L. and Foley Jr., T. Thyroiditis in children. Pediatr. Rev. 1989; 11: 184-91.
2. van Vielet, G. and Delange, F. Goiter and thyroiditis. In: Bertrand, Rappaport, Sizonenko (Eds.) Pediatric Endocrinology, 2nd edn. Baltimore: Williams & Wilkins, 1993; 270-6.
3. Fisher, D. The thyroid. In: Kaplan, S. (Ed.) Clinical Pediatric Endocrinology. Philadelphia: Saunders, 1990; 87-126.
4. Baekkeskov, S., Nielsen, J.H., Marner, B., Bilde, T., Ludvigsson, J. and Lernmark, Å. Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature 1982; 298: 167-9.
5. Baekkeskov, S., Landin, M., Kristensen, J., Srikanta, S., Bruining, G., Mandrup-Poulsen, T. et al. Antibodies to a Mr 64000 human islet cell antigen precede the clinical onset of insulin dependent diabetes. J. Clin. Invest. 1987; 79: 926-34.
6. Baekkeskov, S., Aanstoot, H.-K., Christgau, S., Reetz, A., Solimena, M., Cascalco, M. et al. Identification of the 64k autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990; 347: 151-6.
7. Christie, M., Landin-Olsson, M., Sundkvist, G., Dahlquist, G. and Lernmark, Å. Antibodies to a Mr-64000 islet cell protein in Swedish children with newly diagnosed type 1 (insulin-dependent) diabetes. Diabetologia 1988; 31: 597-602.
8. Atkinson, M. and Maclaren, N. Islet cell antigens in insulin-dependent diabetes. J. Clin. Invest. 1993; 92: 1608-16.
9. Palmer, J.P., Asplin, C.M., Clemons, P., Lyen, K., Tatpati, O., Raghu, P.K. et al. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983; 222: 1337-9.
10. Dean, B.M., Becker, F., McNally, J.M., Tarn, A.C., Schwartz, G., Gale, E.A.M. et al. Insulin antibodies in the prediabetic period: correlation with islet cell antibodies and development of diabetes. Diabetologia 1986; 29: 339-42.
11. Wilkin, T., Armitage, M., Casey, C., Pyke, D., Hoskins, P., Rodier, M. et al. Value of insulin autoantibodies as serum markers for insulin-dependent diabetes mellitus. Lancet. 1985; 1: 480-2.
12. Palmer, J.P. and Lernmark, Å. Pathophysiology of type 1 (insulin-dependent) diabetes. In: Rifkin H, Porte D. (Eds.) Diabetes Mellitus Elsevier, New York, 1990; 414-35.
13. Lernmark, Å. Islet cell antibodies-theoretical and practical implications. Diabetic Medicin. 1987; 4: 285-92.
14. Bottazzo, G.F., Florin-Christensen, A. and Doniach, D. Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974; 2: 1279-83.
15. Lendrum, R., Walker, G., Cudworth, A.G., Theophanides, C., Pyke, D.A., Bloom, A. et al. Islet cell antibodies in diabetes mellitus. Lancet 1976; 2: 1273-6.
16. Spencer, K.M., Tarn, A., Dean, B.M., Lister, J. and Bottazzo, G.F. Fluctuating islet cell autoimmunity in unaffected relatives of patients with insulin-dependent diabetes. Lancet 1984; 1: 764-6.
17. Landing, B., Pettit, M., Wiens, R., Knowles, H. and Guest, G. Antithyroid Antibody and Chronic Thyroiditis in Diabetes. J. Clin. Endocrinol. Metab. 1963; 23: 119-20.
18. Lindberg, B., Ivarsson, S.-A., Ericsson, U.-B. and Ljung, R. High prevalence of thyroid antibodies at diagnosis of Type 1 diabetes mellitus in Swedish children. J. Lab. Clin. Med. 1997; 130: 585-9.
19. Nuovo, J., Baker, J., Wartofsky, L., Lukes, Y. and Burman, K. Autoantibodies to insulin are present in sera of patients with autoimmune thyroid disease. Diabetes 1988; 37: 317-20.
20. Kawasaki, E., Abiru, N., Yano, M. et al. Autoantibodies to glutamic acid decarboxylase in patients with autoimmune thyroid disease: relation to competitive insulin autoantibodies. J. Autoimmun. 1995; 8: 633-43.
21. Vardi, P., Modan-Mozes, D., Ish-Shalom, S., Soloveitzik, L., Barzilai, D. and Modan, M. Low titer, competitive insulin autoantibodies are spontaneously produced in autoimmune diseases of the thyroid. Diabetes Res. Clin. Pract. 1993; 21: 161-6.
22. Ng, W., Thai, A., Lui, K. and Cheah, J. Occurrence of antibodies to insulin in patients with autoimmune thyroid disease. Ann. Acad. Med. Singapore 1993; 22: 544-8.
23. Lindberg, B., Ahlfors, K., Carlsson, A., Ericsson, U.-B., Landin-Olsson, M., Å. Lernmark, et al. (1999) Prior exposure to measles, mumps, and rubella - but not vaccination during adolescence correlates to the prevalence of pancreatic and thyroid autoantibodies. Pediatrics 104/e12, 1-5 [www http://www.pediatrics org/ cgi/content/full/104/1/e12].
24. Riley, W.J., Maclaren, N.K., Krischer, J., Spillar, R.P., Silverstein, J.H., Schatz, D.A. et al. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N. Engl. J. Med. 1990; 323: 1167-72.
25. Bingley, P.J., Christie, M.R., Bonifacio, E., Bonifanti, R., Shattock, M., Fonte, M.T. et al. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 1994; 43: 1304-10.
26. Lipton, R., Atchison, J., Dorman, J. et al. Genetic, immunological and metabolic determinants of risk for Type 1 diabetes mellitus in families. Diabetic Medicine 1992; 9: 224-32.
27. Bloom, A., Hayes, T. and Gamble, D. Register of newly diagnosed diabetic children. Br. Med. J. 1975; 2: 580-3.
28. Dahlquist, G., Blom, L. and Lönnberg, G. The Swedish childhood diabetes study a multivariate analysis of risk determinants for diabetes in different age groups. Diabetolagia 1991; 34: 757-62.
29. Schatz, D., Krischer, J., Home, G. et al. Islet cell antibodies predict insulin-dependent diabetes in United States school age children as powerful as in unaffected relatives. J. Clin. Invest. 1994; 93: 2403-7.
30. Lévy-Marchal, C., Tichet, J., Fajardy, I., Gu, X., Dubois, F. and Czernichow, P. Islet cell antibodies in normal French schoolchildren. Diabetologia 1992; 35: 577-82.
31. Bingley, P., Bonifacio, E., Shattock, M. et al. Can islet cell antibodies predict IDDM in the general population? Diabetes Care 1993; 16: 43-50.
32. Tandon, N., Zhang, L. and Weetman, A. HLA associations with Hashimoto's thyroiditis. Clin. Endocrinol. 1991; 40: 3836.
33. Bazarova, E., Efuni, S., Polianskaia, I., Fedoseeva, G. and Okeanova, T. Association of antigens of the HLA system and Hashimoto's thyroiditis. Probl. Endokrinol. 1988; 34: 14-16.
34. Farid, N. and Thompson, C. HLA and autoimmune endocrine disease. Mol. Biol. Med. 1986; 3: 85-97.
35. Bogner, U., Badenhoop, K., Peters, H., Schmieg, D., Mayr, W., Usadel, K. et al. HLA-DR/DQ gene variation in nongoitrous autoimmune thyroiditis at the serological and molecular level. Autoimmunity 1992; 14: 155-8.
36. Jenkins, D., Penny, M., Fletcher, J., Jacobs, K., Mijovic, C., Franklyn, J. et al. HLA class II gene polymorphism contributes little to Hashimoto's thyroiditis. 1992; Clin. Endocrinol. 1992; 37: 141-5.
37. Wolf, E., Spencer, K. and Cudworth, A. The genetic susceptibility to Type 1 (insulin-dependent)diabetcs: analysis of the HLA-DR association. Diabetologia 1983; 24: 224-30.
38. Platz, P., Jacobson, B., Morling, N. et al. HLA-D and DR-antigens in genetic analysis of insulin-dependent diabetes mellitus. Diabetologia 1981; 21: 108-15.
39. Grubin, C.E., Daniels, T., Toivola, B., Landin-Olsson, M., Hagopian, W.A., Li. L. et al. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 1994; 37: 344-50.
40. 3H recombinant human ligands. J. Immunol. Meth. 1995; 186: 89-99.
41. Madsen, O., Landin-Olsson, M., Bille, G., Sundkvist, G., Lernmark, Å., Dahlqvist, G. et al. A two-colour immunofluorescence test with a monoclonal human proinsulin antibody improves the assay for islet cell antibodies. Diabetologia 1986; 29: 115-18.
42. Landin-Olsson, M., Sundkvist, G. and Lernmark, Å. Prolonged incubation in the two-colour immunofluorescence test increases the prevalence and titres of islet cell antibodies in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1987; 30: 327-32.
43. Bonifacio, E., Lernmark, Å., Dawkins et al. Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies. J. Immunol. Meth. 1988; 106: 83-8.
44. Greenbaum, C.J., Palmer, J.P., Nagataki, S., Yamaguchi, Y., Molenaar, J.L., Van Beers, W.A. et al. Improved specificity of ICA assays in the fourth international immunology of diabetes serum exchange workshop. Diabetes 1992; 42: 1570-4.
45. Ericsson, U.-B., Larsson, I., Murne, A. and Thorel, I. A new sensitive immunosorbent radioassay for the detection of circulating antibodies to polypeptide hormones and protein. Scand. J. Clin. Lab Invest. 1984; 44: 487-93.
46. Kockum, I., Wassmuth, R., Holmberg, E., Michelsen, B. and Lernmark, Å. HLA-DQ primarily confers protection and HLA-DR susceptibility in type 1 (insulin-dependent) diabetes in population-based affected families and control. Am. J. Hum. Genet. 1993; 53: 150-67.
47. Olerup, O. and Zetterquist, H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 h: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39: 225-35.
48. Christie, M. and Delovitch, T.L. Persistence of antibodies to a 64,000-Mr islet cell protein after onset of type 1 diabetes. Diabetes 1990; 39: 653-9.
49. Yokota, I., Matsuda, J., Naito, E., Ito, M., Shima, K. and Kuroda, Y. Comparison of GAD and ICA512/IA-2 antibodies at and after the onset of IDDM. Diabetes Care 1998; 21: 49-52.
50. Sundkvist, G., Hagopian, W.A., Landin-Olsson, M., Lernmark, Å, Ohlsson, L., Ericsson, C. et al. Islet cell antibodies (ICA) but not glutamic acid decarboxylase antibodies (GAD65-Ab) are decreased by plasmapheresis in patients with newly diagnosed insulin-dependent diabetes mellitus (IDDM). J. Clin. Endocrinol. Metab. 1994; 78: 1159-65.
51. Landin-Olsson, M., Palmer, J., Lernmark, Å. et al. Predictive value of islet cell and insulin autoantibodies for type 1 (insulin-dependent) diabetes mellitus in a population-based study of newly-diagnosed diabetic and matched control children. Diabetologia 1992; 35: 1068-73.
52. Casali, P., Nakamura, M., Ginsberg-Fellener, F. and Notkins, A. Frequency of B cells committed to the production of antibodies to insulin in newly diagnosed patients with IDDM and generation of high affinity human monoclonal IgG to insulin. J. Immunol. 1990; 144: 3741-7.
53. Landin-Olsson, M., Karlsson, A., Duhlquist, G., Blom, L., Lernmark, Å. and Sundkvist, G. Islet cell and other organ-specific autoantibodies in all children developing type I (insulin-dependent) diabetes mellitus in Sweden during one year and in matched controls. Diabetologia 1989; 32: 387-95.
54. Lèvy-Marchal, C., Dubois, F., Noël, M., Tichet, J. and Czernichow, P. Immunogenetic Determinants and Prediction of IDDM in French schoolchildren. Diabetes 1995; 44: 1029-32.
55. Boem, B., Manfras, B., Scißler, J. et al. Epidemiology and immunogenetic background of islet cell antibody-positive nondiabetic schoolchildren. Diabetes 1991; 40: 1435-9.
56. Karjalainen, J. Islet cell antibodies as predictive markers for IDDM in children with high background incidence of disease. Diabetes 1990; 39: 1144-50.
57. Riley, W. and Maclaren, N. Islet-cell antibodies are seldom transient. Lancet 1984; i: 1351-2.
58. Gardas, A. Laboratory tests: levels of T3, T4, TSH and antithyroid gland autoantibodies in the Polish population. Endokrynol. Pol. 1991; 42: 353-8.
59. Ericsson, U.-B. and Ivarsson, S.-A. Thyroglobulin autoantibodies in children and adolescents: Its relation to thyroid disease. Ped. Asthma All Immunol. 1989; 3: 233-6.
60. Verge, C., Gianni, R., Kawasaki, E. et al. Number of autoantibodies rather than particular autoantibody specificities determines risk of Type 1 diabetes. J. Autoimm. 1996; 9: 379-83.
61. Christie, M., Roll, U., Payton, M., Hatfield, E. and Ziegler, A. Validity of screening for individuals at risk for type 1 diabetes by combined analysis of antibodies to recombinant proteins. Diabetes Care 1997; 20: 965-70.